Publications by authors named "S K Zawadzka-Leska"

Article Synopsis
  • Azacitidine (AZA) is the primary treatment for higher-risk myelodysplastic syndrome (HR-MDS) patients who cannot undergo intensive therapy, but outcomes can vary between clinical trials and real-life applications.
  • A study involving 315 patients treated with AZA showed that 24% experienced early treatment failure, with serum albumin levels serving as a key predictor for this outcome.
  • Overall, the study concluded that evaluating serum albumin levels prior to treatment can help identify patients at higher risk for early failure and worse survival outcomes.
View Article and Find Full Text PDF

Context: Some adrenal tumors, such as pheochromocytoma, can be life-threatening. Therefore it is crucial to distinguish them from other lesions, especially prior to surgery. Chromogranin A (CgA) seems to potentially be a good marker for tumors of chromaffin origin.

View Article and Find Full Text PDF